Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08 mai 2024 11h31 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Trading in Novo Nordisk shares by board members, executives and associated persons
06 mai 2024 15h02 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk A/S - share repurchase programme
06 mai 2024 14h44 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
06 mai 2024 14h40 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
03 mai 2024 13h48 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024
02 mai 2024 01h30 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 May 2024 - financial report for the period 1 January 2024 to 31 March 2024 Operating profit increased by 27% in Danish kroner and by 30% at constant exchange rates (CER) to DKK...
Novo Nordisk A/S - share repurchase programme
01 mai 2024 08h30 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
26 avr. 2024 06h16 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
Vedtægter for Novo Nordisk, april 2024
24 avr. 2024 08h57 HE
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk, april 2024
Vedhæftet fil
Vedtægter 24 Apr 2024
...
Novo Nordisk A/S - Articles of Association, April 2024
24 avr. 2024 08h57 HE
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association, April 2024
Attachment
Articles of Association 24 Apr 2024
...